NIFTY  9,360.55  -0.27%
  SENSEX  30,301.60  -0.21%
 CURRENCY  Rs  64.89/$ 72.59/€, 84.18/£
  GOLD  28,700.00  -0.39%
  SILVER  39,744.00  -0.54%
  DAX  12,659.20  0.31%
  FTSE  7,485.29  -0.15%
  CAC  5,348.16  0.41%
  HANG SENG  25,428.50  0.10%
  NIKKEI  19,743.00  0.66%
  Shanghai Composite  3,064.08  0.03%
  DOW JONES  20,937.90  0.21%
  NASDAQ  6,138.71  0.08%
  S&P 500  2,398.42  0.18%
SOURCES TO COGENCIES : Cabinet Approves Proposal For Abolition Of Foreign Investment Promotion Board SOURCES TO COGENCIES : Cabinet Approves Proposal On 2017-18 Sugarcane Prices SOURCES TO COGENCIES : Need For Cabinet Nod For FDI Over Rs 5000 Cr To Remain TATA INVEST Q4 EARNINGS : PAT Rs 16.1 Cr Vs Rs 22.3 Cr YoY TATA INVEST Q4 EARNINGS : Revenue Rs 35.8 Cr Vs Rs 32.3 Cr YoY TATA INVEST Q4 EARNINGS : To Pay Dividend Of Rs 18/Share PRASUN GAJRI HDFC LIFE : I.T. Stocks May Perform Better On A Short-Term Basis FROM REUTERS : KOC & Tata Group Sign Joint Venture To Tap Into White Goods Consumer Market

Pepsodent Vs Colgate: Ad Wars!

Video:

Play this video

It is a war out there in the FMCG sector, to grab a larger pie of the Rs.6,000 crore oral care market. Recently, HUL took on market leader Colgate with a no-holds-barred ad campaign for Pepsodent 'Germicheck' toothpaste. TV and print was inundated with the ad, which compares Pepsodent with Colgate. Bloomberg TV India asks ASCI Chairman Arvind Sharma whether naming competitors in an ad crosses a line.